comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Complement inhibition - Page 1 : comparemela.com
Use of Povetacicept in Treatment of IgA Nephropathy
Drs Jonathan Barratt and Brad Rovin comment on clinical trial data regarding the use of povetacicept for the treatment of IgAN.
United-states
American
Brad-rovin
Jonathan-barratt
American-society-of-nephrology
American-society
Povetacicept
Wigan
Nephropathy
Proteinuria
Complement-inhibition
B-cell-modulation
Dual Inhibition of BlyS and APRIL in IgA Nephropathy
Nephrology experts explore the role of dual inhibition of BlyS and APRIL in the treatment of IgAN, and how this can impact disease pathogenesis.
Jonathan-barratt
Brad-rovin
Wigan
Nephropathy
Proteinuria
Complement-inhibition
B-cell-modulation
Blys-april-targeting
New Therapies in IgA Nephropathy
Brad Rovin, MD, outlines the use of complement inhibitors as an alternative to systemic glucocorticoids for the treatment of IgAN.
Brad-rovin
Jonathan-barratt
Wigan
Nephropathy
Proteinuria
Complement-inhibition
B-cell-modulation
Blys-april-targeting
The Pathophysiology of IgAN and Use of Immunomodulating Therapies
An expert nephrologist provides an overview of the pathophysiology of IgAN before discussing new immunomodulating therapies in clinical trials.
Milan
Lombardia
Italy
China
Chee-kay-cheung
European-renal-association
Visionary-study
Wigan
Nephropathy
Pathophysiology
Pro-inflammatory-effect
Mesangial-cell-activation
Complement therapy in transplant patients in C3G
Anuja Java, MD, discusses the role of complement inhibitors in transplant patients with C3G.
Jonathan-barratt
Kidney-transplant
Complement-inhibition
Wigan
C3g
Nephropathy
C3-inhibitor
Infections
vimarsana © 2020. All Rights Reserved.